Additionally, an anti-EpCAM(scFv)–MAP fusion protein showed promising results with IC50 values of 43 and 67 nmol/L against L3.6pl and A431 EpCAM+ cancer cell lines, which is also comparably better when compared with that obtained for anti-EpCAM(scFv)–ETA’ (409 nmol/L on L3.6pl and 91 nmol/L on A431 [60]. Here, EPCAM is linked to cancer.